Kurt R. Gehlsen
Directeur Technique/Scientifique/R&D chez Biorasi LLC
Profil
Kurt R.
Gehlsen is currently the Chief Scientific Officer & Vice President at Biorasi LLC.
Previously, he worked as the Chief Science Officer at Maxim Pharmaceuticals, Inc. from 1996 to 2006.
He also held a position as a Principal at the California Institute of Technology.
Dr. Gehlsen obtained his undergraduate and doctorate degrees from the University of Arizona.
Postes actifs de Kurt R. Gehlsen
| Sociétés | Poste | Début |
|---|---|---|
Biorasi LLC
 Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Directeur Technique/Scientifique/R&D | 29/01/2019 |
Anciens postes connus de Kurt R. Gehlsen
| Sociétés | Poste | Fin |
|---|---|---|
| Maxim Pharmaceuticals, Inc. | Directeur Technique/Scientifique/R&D | 06/01/2006 |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - |
Formation de Kurt R. Gehlsen
| University of Arizona | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Maxim Pharmaceuticals, Inc. | Health Technology |
Biorasi LLC
Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Health Technology |
